Quaestus Capital Management led the Series A round to support international growth and sustainable ad technology.
"At the heart of our industry is an inherent value exchange between advertiser and consumer, and I’m on a mission to harness that value as a significant force for good. Through our respectful, positive ad platform, brands can treat people online as partners, rather than targets, united by a desire to have a meaningful social impact. Backing from industry experts like QCM and First Party Capital, social impact investors and, indeed, the general public, will help to supercharge our growth whilst keeping us true to our values at every step along the way."
TRICAPITAL led the investment round with backing from a syndicate of Scottish investors.
"Our next phase of growth will involve building international partnerships, growing the team, and appointing a scientific advisory committee to support the work of the main board."
The syndicate included Mark Bamforth, Tern Plc, SIS Ventures, and Scottish Enterprise.
"2022 promises to be a big year for Talking Medicines with this new investment. Having scaled up our operations and formally launched our PatientMetrx® technology platform, we’ve now got our sights set on expanding in the US pharma market, providing brand teams and agencies with a new way of understanding what patients are really saying and feeling about their medicines. The pharmaceutical industry will go through seismic change this year and our actionable patient insights will be transformational for the industry. Our new office in New Jersey provides the ideal base for us to build relationships with customers, acquire new leads and drive revenue growth."
The equity and debt round was backed by Force Over Mass, PostFinance, 1818 Venture Capital, and Tribe Capital to fund increased lending volumes.
"Our ambition is for Outfund to be the place to go to grow your business, without compromising your equity or wasting time fundraising. This is why we have spent time developing a way to make the process of securing money for growth easier, fairer and, most importantly, faster. Our approach has been warmly received by the founders and directors so far, and now we’re looking at how we can open this up to more businesses and continue to be part of their journey to success for a long time."
The seed round was led by Point Nine with backing from 20VC and Entrepreneur First.
"I’m a big fan of sharing funny GIFs with friends, but for high quality product animations, we need a format and tool that’s fit for purpose. With LottieLab, we are decluttering the motion design process and bringing it into the 21st century. LottieLab has all the benefits of modern design tools fit for today’s product development teams; being web-based, collaborative and simple, and crucially, there’s no After Effects qualification needed to use it. This is one of the first steps we are taking towards our mission of democratising motion design for everyone, everywhere and to create a world of storytellers, making the web more fun through animations. I’m over-the-moon that Point Nine and our other investors have decided to join us on this journey."
